Clinical trial
Stereotactic Body Radiation Therapy and vNKT Cell Adoptive Therapy for Advanced Pancreatic Cancer: a Phase 2 Trial
NCT05783076 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stereotactic Body Radiation Therapy and vNKT Cell Adoptive Therapy for Advanced Pancreatic Cancer: a Phase 2 Trial
- Lead sponsor
- Changhai Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 25, 2023
- Completion date
- March 1, 2025
- Enrollment
- 29 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatic cancer